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Background: The treatment of aortic coarctation with percutaneous stent placement has evolved rapidly in the past decade, and 
has proved to be an excellent alternative for surgical treatment for this common congenital defect. After stent placement, antiplatelet 
therapy has been suggested by some groups to prevent stent thrombosis, although infrequent, because the aorta is a high flow vessel. 
Nevertheless there are no guidelines addressing the management of this complication.
case:  A 29 year old male with a history of hypertension was diagnosed with aortic coarctation. A CT angiography was performed and 
the patient was considered suitable for percutaneous treatment. A Palmaz stent was placed, with proper expansion achieved, leaving a 
3 mmHg residual gradient. He was discharged on losartan, and aspirin. Three days later, the patient presented to the emergency room 
with a six hour history of acute pain, paresthesia, pallor and weakness of the right lower limb. The physical exam revealed hypotension, 
diaphoresis and absence of pulse of the abovementioned limb. Also acute renal failure was diagnosed (serum creatinine of 2.5 mg/dL).
decision Making:  An urgent CT angiography was performed which showed, early thrombosis of the stent, extending to the common and 
external iliac artery. The patient was not considered suitable for surgical or percutaneous treatment. Intravenous thrombolytic treatment 
was administered, with alteplase, 90 mg over 2 hours, and pain control medication as needed. Six hours later the symptoms resolved 
and distal pulses were restored. A second CT angiography was obtained showing complete permeability of the stent, without any residual 
thrombus. Thrombophilia was ruled out. Oral anticoagulation treatment was continued for six months. On follow-up, after two years, the 
patient remains asymptomatic and with a patent aortic stent.
conclusion:  Aortic stent thrombosis is a rare complication, treatment is challenging, and intravenous thrombolysis may be an adequate 
alternative in patients who cannot be treated by surgical or percutaneous means. Oral anticoagulation after thrombolysis might be 
reasonable, and thrombophilia should be ruled out.
